CVE Intelligence
High Access control

CVE-2026-28806 — Improper authorization in device bulk actions and device update API allows cross-organization device control

Improper Authorization vulnerability in nerves-hub nerves_hub_web allows cross-organization device control via device bulk actions and device update API. Missing authorization checks in the device bulk actions and device update API endpoints allow authenticated users to target devices belonging to other organizations and perform actions outside of their privilege level. An attacker can select devices outside of their organization by manipulating device identifiers and perform management actions on them, such as moving them to products they control. This may allow attackers to interfere with firmware updates, access device functionality exposed by the platform, or disrupt device connectivity. In environments where additional features such as remote console access are enabled, this could lead to full compromise of affected devices. This issue affects nerves_hub_web: from 1.0.0 before 2.4.0.

Published Mar 10, 2026 · Updated Oct 13, 2026 · Sources: NIST National Vulnerability Database, CVE Program (cve.org) e CISA ADP · CNA: EEF

Who exploits it and how urgent it is

A 0–100 score combining confirmed exploitation, ransomware and APT use, public exploits, EPSS and severity.

No exploitation signal in the sources consulted so far.
How the score was calculated
  • EPSS 0.6% (30-day exploitation probability)+7
  • Technical severity (high)+6

The score orders the patch queue; it does not replace your asset context (internet exposure, criticality, compensating controls).

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the sources call it.

Exploitation
Not confirmed
Not in CISA KEV — an absence of record, not proof it is unexploited.
EPSS FIRST
0.62%
ahead of 49% of scored CVEs · Oct 15, 2026
Affects
Nerves-hub
Nerves Hub Web and 1 more
CVSS base
8.8
High · 3 source(s)

CISA SSVC assessment CISA

Three decision points CISA publishes for the CVEs it assesses (SSVC 2.0.3). A stakeholder decision, not a severity score.

Exploitation
None
none · proof-of-concept · active
Automatable
No
can an attacker script the kill-chain steps
Technical impact
Total
partial · total control of the vulnerable component

Remediation

Fixes and mitigations documented by the sources — linked to the original advisory.

  • Documented patch — cna.erlef.org (NIST National Vulnerability Database)
  • Documented patch — github.com (NIST National Vulnerability Database)
  • Documented patch — github.com (NIST National Vulnerability Database)
  • Documented patch — osv.dev (NIST National Vulnerability Database)

First 24 hours

Ordered from the record’s own fields — exposure first, because you cannot patch what you have not found. A rule-generated starting point.

  1. Identify exposed assets running the affected vendor/product/version combinations (Nerves-hub Nerves Hub Web, Nerves-hub Nerveshub).
  2. Apply the fixed version or the patch documented under Remediation.
  3. Search available logs for exploit probes matching the vulnerability class (access control), errors and authentication anomalies.

Affected scope

Vendor, product and versions as the sources word them.

VendorProductVersionsStatusSource
Nerves-hub Nerves Hub Web ≥ 1.0.0 and < 2.4.0≥ adaeefdb7a835525482588f43332ef988cc448c7 and < 1f69c9d595684a4650c3ac702f3dc7c5bcd7526c Vulnerable CVE Program (cve.org) e CISA ADP
Nerves-hub Nerveshub ≥ 1.0.0 and < 2.4.0 Vulnerable NIST National Vulnerability Database

Attack characteristics

The CVSS vector, decoded. It describes the attack, not your exposure to it.

Attack vector
Network
Attack complexity
Low
Privileges required
Low
User interaction
None
Scope
Unchanged
Confidentiality
High
Integrity
High
Availability
High

Every base score collected

Sources score independently and may disagree; each row says who scored it and under which version.

ScoreVersionSeverityExpl.ImpactScored by
9.4 CVSS 4.0 Critical — — 6b3ad84c-e1a6-4bf7-a703-f496b71e49db via NIST National Vulnerability Database
9.4 CVSS 4.0 Critical — — EEF via CVE Program (cve.org) e CISA ADP
8.8 CVSS 3.1 High 2.8 5.9 nvd@nist.gov via NIST National Vulnerability Database
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H (score shown at the top: nvd@nist.gov)

Weakness MITRE

Weakness class according to MITRE’s CWE catalog.

CWE-285 · Improper Authorization

Other CVEs with this weakness →

EPSS over time FIRST

Oct 13, 2026 → Oct 15, 2026 · 3 reading(s) · max 0.62%

Detection

Read off the CVSS vector and the weakness class. Starting points, not tested rules.

  • Prioritize edge telemetry for the network-reachable component (proxy, WAF, IDS/IPS).
  • Audit administrative actions and access to resources outside each user’s normal pattern.
web/proxy/WAF logsnetwork IDS/IPSauthentication logsapplication logs

Timeline

What happened to this CVE, newest first.

  • 2026
  • Affected products added · nerves-hub/nerves hub web
    Oct 13, 2026 · CVE Program (cve.org) e CISA ADP
  • SSVC assessment updated
    Oct 13, 2026 · CVE Program (cve.org) e CISA ADP
  • Record published
    Oct 13, 2026
  • Fix documented
    Oct 13, 2026 · NIST National Vulnerability Database
  • CVSS changed · 8.8
    Oct 13, 2026 · NIST National Vulnerability Database
  • Source status changed · → Analyzed
    Oct 13, 2026 · NIST National Vulnerability Database
  • Record created in this database
    Oct 13, 2026 · NIST National Vulnerability Database
  • CVE published
    Mar 10, 2026 · EEF

Source activity

Repeated readings are counted rather than listed.

  • 1× Official description updated · Oct 13, 2026 – Oct 13, 2026

References

4 on the record

Elsewhere on this site

Nerves-hub
every CVE for this vendor
Access control
same class
CWE-285
other pages naming this weakness

Related CVEs (same products)

  • CVE-2025-64097 NervesHub has Insufficient Token Entropy that Allows Authentication Bypass via Brute Force Jan 22, 2026

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

  • No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
  • No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
  • No exploit packet captures, log samples, or incident case IDs supplied.

Answered from this record

Text assembled only from the fields above — no additional claims.

What should defenders know first?

CVE-2026-28806 is "Improper authorization in device bulk actions and device update API allows cross-organization device control", rated High. It affects Nerves Hub Web (Nerves-hub); versions are in the scope table. It is not in CISA KEV, which does not rule out exploitation. CVSS 8.8 describes technical severity. EPSS 0.62% estimates the probability of exploitation in 30 days; neither replaces your asset context. First verify whether exposed or business-critical assets run the affected versions, apply vendor fixes or mitigations, and preserve logs for review.

Comments

Moderated technical discussion. Read the community guidelines.

No comments yet.

Sign in or create an account to comment and suggest corrections.